Navigation Links
Beckman Coulter's 4th Quarter and Full Year 2007 Revenue Grows 10.8% and 9.2%, Respectively; 2007 Earnings Per Share Beat Outlook
Date:2/8/2008

ine our Biomedical

Research Division and Diagnostics Division into a single company

structure. During 2006, we incurred charges of $13.2 million for

severance and other restructuring costs and $2.3 million for asset

impairment.

i) Roche Research and Development Charge - During the third quarter

2006, we paid Roche Diagnostic a license fee in the amount of $27.5

million for rights to certain technologies in the clinical

diagnostic field. The payment was recorded as a research and

development charge.

j) Pension Curtailment - During the third quarter 2006, we amended our

pension plans by freezing benefits for certain employees effective

December 31, 2006. As a result of this amendment, we incurred a net

curtailment charge of approximately $4.0 million.

k) Applera - In April 2006, a settlement was reached in a legal dispute

with Applera Corporation, and the parties granted royalty-bearing

licenses to each other for certain patents. Applera's Applied

Biosystems Group made a $35.0 million special payment to us, and we

will pay Applera $20 million over 10 quarters for rights to certain

technologies in the diagnostics market. As a result, we recorded a

$35 million gain and an $18.9 million research and development

charge in connection with this settlement in the second quarter of

2006.

l) Investigation Charges - During the second quarter 2006, the Audit

and Finance Committee of our Board of Directors oversaw an

investigation of claims made by a former employee. The Audit and

Finance Committee retained outside counsel and an independent

accounting firm to assist in the investigation and concluded that

the allegations were not substantiated and that ou
'/>"/>

SOURCE Beckman Coulter, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related medicine news :

1. Beckman Coulter Announces Licensing Option Agreements for Cancer Genes with Johns Hopkins University
2. Beckman Coulter Signs Agreements With Amerinet, Inc.; Ten-Year Partnership Extended for Another Three Years
3. Beckman Coulter to Present at the Credit Suisse Global Healthcare Conference
4. Beckman Coulter to Acquire Flow Cytometry Instrumentation Business From Dako
5. Beckman Coulter to Present at the 2007 RBC Capital Markets Healthcare Conference
6. Haemacure Reports Third Quarter 2007 Results
7. Weight Watchers Declares Quarterly Dividend
8. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
9. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
10. Medical Services International Maintains Pace in Second Quarter
11. Martek Announces Third Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 30, 2014 Daily Gossip indicates in its ... easily. A panic attack is a feeling of intense stress ... are a series of symptoms that sufferers commonly deal with ... of breath, stress or anxiety. Naturally, panic attacks deeply affect ... way to overcome them. , The 60 Second Panic Solution ...
(Date:7/30/2014)... The Restore My Blood Sugar review recently ... sugar levels can now find an amazingly successful method of ... was created by D. Chao and Andrew Forester who claim ... when it comes to normalizing blood sugar levels. Chao actually ... secret to the cure of diabetes that all patients should ...
(Date:7/30/2014)... 30, 2014 Within weeks freshman will begin to ... Each hopes this will be a time of growth and the ... to pause; it may not be as easy as it looks. ... will switch their major at least once and many will switch ... and the costs are exacerbated when switching in the later years ...
(Date:7/30/2014)... July 30, 2014 Ticket Down ... Bayern Munich vs. Chivas Guadalajara friendly exhibition match at ... World Cup, the one team that was left standing as ... made it through the world’s largest football competition and even ... their way to the cup. Germany was led by seven ...
(Date:7/30/2014)... HealthDay Reporter WEDNESDAY, July 30, 2014 ... to develop dementia, but researchers have been unable to explain ... Specifically, they haven,t been able to figure out the direction ... on dementia, or does dementia cause people to become depressed? ... journal Neurology sheds more light on the mystery. ...
Breaking Medicine News(10 mins):Health News:60 Second Panic Solution Review Reveals Unique Way to Stop Panic Attacks 2Health News:Restore My Blood Sugar Review Reveals Exclusive Ways to Normalize Blood Sugar 2Health News:Advice to College Freshman from Author Garrett Miller 2Health News:Advice to College Freshman from Author Garrett Miller 3Health News:Bayern Munich vs. Chivas Guadalajara Tickets Red Bull Arena: Ticket Down Slashes Ticket Prices for Chivas Guadalajara vs. Bayern Munich in Harrison, NJ 2Health News:Bayern Munich vs. Chivas Guadalajara Tickets Red Bull Arena: Ticket Down Slashes Ticket Prices for Chivas Guadalajara vs. Bayern Munich in Harrison, NJ 3Health News:Scientists Shed Light on Link Between Depression, Dementia 2Health News:Scientists Shed Light on Link Between Depression, Dementia 3
... 16 A grassroots,effort to promote advance care planning ... than 450 participating organizations in,all 50 states. The first ... a year ago and implemented with no budget or,full-time ... am blown away by the response to our grassroots ...
... know anyone,who,s a Type-A personality? A multi-tasking, go-getter? ... would turn out to be Type-A.,There,s a lot ... But the antioxidants,deserve some special attention., (Photo: ... food by their deep-colored pigment - such as ...
... thinking skills, study finds , , WEDNESDAY, April 16 (HealthDay News) ... than women to develop mild cognitive impairment, new research shows. ... found more women than men [or an equal proportion] have ... men," study author Rosebud Roberts, of the Mayo Clinic in ...
... Abstract 19, Study highlights:, -- Low ... prevalence,of peripheral arterial disease (PAD) in a study that ... feel this needs further study and do not recommend,people ... by,their doctors., -- The American Heart Association recommends ...
... patient care while ... saving Medicaid dollars, ... Best Practices in Consumer Empowerment and,Protection Awards competition, naming the ... Eli Lilly,and Company as Silver Award winners in the Health ...
... Challenges Facing the ... Healthcare Industry, ... association with U.S. News & World Report,hosted an exclusive panel ... the National Press Club in Washington, D.C.,The event, attended by ...
Cached Medicine News:Health News:More Than 350 Events Today in Recognition of First National Healthcare Decisions Day 2Health News:Cranberries: The Little Fruit With a Great Big Punch 2Health News:Cranberries: The Little Fruit With a Great Big Punch 3Health News:Low Vitamin D Levels Associated With an Increased Risk of Peripheral Arterial Disease 2Health News:Low Vitamin D Levels Associated With an Increased Risk of Peripheral Arterial Disease 3Health News:Mental Health Prescription Program Named Winner in URAC's Best Practices in Consumer Empowerment and Protection Awards 2Health News:Mental Health Prescription Program Named Winner in URAC's Best Practices in Consumer Empowerment and Protection Awards 3Health News:Mental Health Prescription Program Named Winner in URAC's Best Practices in Consumer Empowerment and Protection Awards 4Health News:Siemens Addresses Cost vs. Value Issues In Healthcare and Technology 2Health News:Siemens Addresses Cost vs. Value Issues In Healthcare and Technology 3
(Date:7/30/2014)... Germany , July 30, 2014  invendo ... and computer-assisted ("robotic") colonoscopy system, today announced the appointment ... medical device executive, as a new member of its ... highly respected global visionary in the medical device industry. ... and Chief Executive Officer at Given Imaging Ltd. (NASDAQ/TASE: ...
(Date:7/30/2014)... and PARIS , July 30, 2014 ... and Sanofi (EURONEXT: SAN and NYSE: SNY ... trials of alirocumab in people with hypercholesterolemia met their ... baseline in low-density lipoprotein cholesterol (LDL-C) at 24 weeks ... investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type ...
(Date:7/30/2014)... , July 30, 2014  DigiPath, Inc. (OTCBB ... is expanding into the cannabis testing and education markets, ... its business and affairs not previously disclosed or, to ... recent unusual market action. "We have noticed ... the last three trading days," said Steve Barbee ...
Breaking Medicine Technology:invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 2invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8DigiPath No New Corporate Developments 2
... Jan. 5, 2012  Isis Pharmaceuticals, Inc. (NASDAQ: ... Phase 1 study with ISIS-TTRRx.  The results demonstrated ... reductions of greater than 80 percent in transthyretin ... well tolerated with no significant adverse events.  ISIS-TTRRx ...
... (NASDAQ: AMRI ), a global contract services ... preferred provider agreement with BioPontis Alliance LLC. The agreement ... gap between early-stage research and technologies being discovered and ... provide its services in small molecule discovery, development, and ...
Cached Medicine Technology:ISIS Reports Phase 1 Data Demonstrating ISIS-TTRRx Produces Significant Reductions in TTR Protein 2ISIS Reports Phase 1 Data Demonstrating ISIS-TTRRx Produces Significant Reductions in TTR Protein 3ISIS Reports Phase 1 Data Demonstrating ISIS-TTRRx Produces Significant Reductions in TTR Protein 4AMRI Announces Preferred Provider Agreement with BioPontis Alliance LLC 2AMRI Announces Preferred Provider Agreement with BioPontis Alliance LLC 3
Inquire...
Bench Top Class I Containment Cabinet Personnel Protection...
Inquire...
... internal calibration mass for convenient ... of Fully Automatic Self-Calibration at ... changes are detected, or touch-key ... RS232 Interface, Shimadzu WindowsDirect communication ...
Medicine Products: